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Abstract
Increasing evidence links metabolic signals to cell proliferation, but the molecular wiring that connects the two core
machineries remains largely unknown. E2Fs are master regulators of cellular proliferation. We have recently shown that E2F2
activity facilitates the completion of liver regeneration after partial hepatectomy (PH) by regulating the expression of genes
required for S-phase entry. Our study also revealed that E2F2 determines the duration of hepatectomy-induced hepatic
steatosis. A transcriptomic analysis of normal adult liver identified ‘‘lipid metabolism regulation’’ as a major E2F2 functional
target, suggesting that E2F2 has a role in lipid homeostasis. Here we use wild-type (E2F2+/+) and E2F2 deficient (E2F22/2)
mice to investigate the in vivo role of E2F2 in the composition of liver lipids and fatty acids in two metabolically different
contexts: quiescence and 48-h post-PH, when cellular proliferation and anabolic demands are maximal. We show that liver
regeneration is accompanied by large triglyceride and protein increases without changes in total phospholipids both in
E2F2+/+ and E2F22/2mice. Remarkably, we found that the phenotype of quiescent liver tissue from E2F22/2mice resembles
the phenotype of proliferating E2F2+/+ liver tissue, characterized by a decreased phosphatidylcholine to phosphatidyleth-
anolamine ratio and a reprogramming of genes involved in generation of choline and ethanolamine derivatives. The
diversity of fatty acids in total lipid, triglycerides and phospholipids was essentially preserved on E2F2 loss both in
proliferating and non-proliferating liver tissue, although notable exceptions in inflammation-related fatty acids of defined
phospholipid classes were detected. Overall, our results indicate that E2F2 activity sustains the hepatic homeostasis of major
membrane glycerolipid components while it is dispensable for storage glycerolipid balance.
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Introduction
The mammalian liver is a lipidostat that plays a central role in
whole body lipid metabolism. Healthy livers regenerate efficiently
after partial hepatectomy (PH). Successful regeneration requires
replenishing all of the various epithelial and stromal cell types that
compose the liver and a complex matrix remodeling to restore
tissue homeostasis. Following resection of 70% of adult liver, 90-
95% of the remaining hepatocytes leave their quiescent state and
quasi-synchronously reenter the cell-cycle to begin regeneration
[1]. Hepatocytes are the first cells reentering the cell-cycle,
followed by biliary epithelial cells and stromal cells (Kupffer cells
and stellate cells) 48 hours later, and sinusoidal endothelial cells,
96 hours later [2,3]. Maximum DNA synthesis takes place within
the initial 40-48 hours after PH in mice [3–5], which poses a
dramatic demand of biomass formation to make daughter cells:
fatty acids (FA), amino acids and other molecular building blocks.
As blood glucose and hepatic glycogen levels decrease drastically a
few hours after PH, peripheral lipid metabolism becomes essential
for liver cells to fuel required ATP generation [6–8]. Likewise, the
hepatic accumulation of lipid droplets (LDs) plays a key role for
transiently storing lipids that are necessary for metabolic energy
and membrane precursors [9].
Many cell-cycle regulators are known to contribute to liver
regeneration [10–13]. We have recently demonstrated that E2F2
transcription factor is required for mature hepatocytes to exit
quiescence and enter the cell-cycle after PH [5]. Disruption of the
E2F2 gene in hepatocytes led to a reduced rate of S-phase entry
and to delayed liver regeneration, along with prolonged hepatec-
tomy-induced steatosis. By contrast, other members of the E2F
family (E2F1 and E2F4) are dispensable for this function [14,15].
E2F2 is a member of a family of transcription factors (E2F1-8) that
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were originally described as regulators of genes that are critical for
cell-cycle progression [16]. Several members of the family,
including E2F2, display both activator and repressor transcrip-
tional activities, depending on the cellular context. They function
as negative regulators of transcription when bound to hypopho-
sphorylated retinoblastoma in quiescence, or in association with
other transcriptional regulators [17;18]. By contrast, they activate
transcription when released from the repressor complexes after
retinoblastoma is phosphorylated by cyclins and cyclin-dependent
kinases in G1 [17,18]. This duality of functions is also reflected in
their functional role in cell-cycle control. For example, E2F2
contributes to promote cell division in mouse embryonic
fibroblasts [19], hematopoyetic progenitor cells [20] and regener-
ating hepatocytes [5]. Conversely, this E2F is essential for the
maintenance of quiescence in lymphoid and pancreatic cells, and
its loss results in unscheduled entry in the cell-cycle [21–23].
Transcriptomic studies have revealed that E2F factors not only
regulate the expression of genes involved in cell-cycle control.
Genes involved in differentiation, apoptosis, autophagy or
metabolism are also regulated by E2Fs [21,24,25]. In E2F2-/-
regenerating liver [5], aberrant expression of a number of genes
involved in the metabolism of triacylglycerols (TAG) and
phospholipids (PL) suggested that both lipid synthesis and
metabolism might be differentially regulated in proliferating
E2F2-/- hepatocytes, and that E2F2-regulated transcripts in the
quiescent tissue could impact lipid homeostasis during regenera-
tion.
The role of E2F transcription factors in the regulation of
bioenergetics and metabolism is being increasingly recognized
[26]. However, no previous studies have addressed a mechanistic
dependence of lipid metabolism on E2F activity. Our previous
research using E2F2-deficient mice revealed that the E2F2
transcription factor is essential for the liver to develop defined
phenotypic marks that appear during regeneration after PH,
including the timely mobilization of LDs lipids and the regulated
expression of a set of genes involved in lipid metabolism [5].
Lipid homeostasis is a dynamic phenomenon in which import,
synthesis, traffic, degradation and exportation are tightly regulated
in order to maintain a specific lipid composition optimal for their
individual functions. In the current work, we have investigated
whether E2F2 contributes to sustain liver PL and FA compositions
in vivo. Using E2F2+/+ and E2F2-/- mice, we have studied two
metabolically distinctive contexts: (i) quiescent tissue, when E2F2
transcriptional activity is presumably repressed and metabolic
requirements are basal, and (ii) proliferating 48-h post-PH tissue,
when the high metabolic demand that follows resection of 70% of
the liver challenges E2F2 activity [27] and the reprogramming of
whole body lipid metabolism to support proliferation [6–8]. Our
findings indicate that E2F2 gene activity is necessary to sustain
normal PL composition in the adult mouse liver, affecting
particularly the phosphatidylcholine (PC) to phosphatidylethanol-
amine (PE) ratio and the content of defined FA in glycerolipid and
sphingolipid classes.
Material and Methods
Animals and surgical procedure
E2F2+/+ (wild-type, WT) and E2F2-/- mice used in the
described experiments are progeny of the first-generation back-
cross of the E2F2 null allele onto the C57Bl6 genetic background
(mixed C57B16:129Sv strain). All the mice were housed and bred
in our mouse colony at the University of the Basque Country
animal facility, and were genotyped as previously described
[21,22]. In total, 48 eight- to ten-week old female mice were used
in these studies: 24 WT mice and 24 E2F2-/- mice. We used three
cohorts of 8 animals per genotype making a total of 24 E2F2-/-
mice and their respective littermate controls (n = 24) for the
microarray analysis (Tables S1, S2 and S3). Six out of the eight
mice were randomly selected for lipid composition analysis. Thus,
values in Figures 1 and 2 are the result of three independent
experiments using cohorts of 6 E2F2-/- and 6 WT mice each, and
values in Figure 3 and Tables 1 and 2 are the result of two
independent experiments using cohorts of 6 E2F2-/- and 6 WT
mice each. Gene expression analysis by quantitative real-time
PCR was done in 8 mice per genotype except for Scd1 transcript
levels, which were estimated in the 3 pools of 8 mice each from
each genotype (Figure 4).
Partial (70%) hepatectomy was performed under isofluorane
anesthesia according to the Higgins and Anderson method, as
recently described [11]. To minimize inter-variability of regener-
ation outcomes, the surgeries were done by the same investigator.
The animals studied in this work had no apparent suprahepatic
vena cava stenosis. Standard chow diet and water were provided
ad libitum and animals left to recover for 48 hours in the original
thermostatized cage without the use of postoperative analgesia.
Confirming previous observations [5], at 48-h following PH
steatosis reached grade 2 (affecting 33–66% hepatocytes) and liver
mass restoration was similar in the sex- and age-matched WT and
E2F2-/- mice cohorts used here. Liver mass on day 2 doubled in
the two groups, rising from ,30% to ca. 68% of the initial pre-PH
hepatic index, which was also similar in the two experimental
groups (initial liver/body weight ratio was 0.043560.0008 for WT
mice and 0.044560.0008 for E2F2-/- mice).
Animal experiments were approved by the University of the
Basque Country ethical committee CEEA in accordance with the
guidelines of European Research Council for animal care and use.
Liver aliquots were immediately homogenized for lipid analysis or
frozen in liquid N2 and stored at 280uC for mRNA analysis.
Figure 1. E2F2 gene deletion does not promote changes in
total triacylglycerol, phospholipid and protein content in
quiescent liver or at 48-h after 70% partial hepatectomy. Partial
hepatectomy was performed on E2F2+/+ (wild-type, WT) and E2F2-/-
mice, and were sacrificed 48 hours later. Quiescent (0-h, solid bars) and
regenerating (48-h, open bars) livers were harvested and homogenized
and the triacylglycerol (TAG), phospholipid (PL) and protein content of
homogenates were quantified as described in Materials and Methods.
Data are shown as means 6 SD and are representative of three
independent experiments using cohorts of 6 WT and 6 E2F2-/- mice
each. Statistical differences between the regenerating and the
quiescent tissue of a genotype are denoted by * P#0.05, *** P#0.001
(unpaired, 2-tailed Student’s t-test).
doi:10.1371/journal.pone.0112620.g001
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Hepatic lipid analysis
Livers (200 mg) were homogenized in ice-cold phosphate-
buffered saline (10 mM sodium phosphate, pH 7.2, 150 mM
sodium chloride) immediately after surgery (0-h) or euthanasia (48-
h) using a Polytron homogenizer (Brinkmann Instruments, West-
bury, NY). Protein content in homogenates was analyzed using a
bicinconinic acid-based commercial reagent (Bio-Rad). Lipids
were exhaustively extracted from homogenates as described before
Figure 2. E2F2 gene deletion alters the phospholipid composition of quiescent liver. Partial hepatectomy was performed on E2F2+/+ (wild-
type, WT) and E2F2-/- mice, and were sacrificed 48 hours later. Quiescent (0-h, solid bars) and regenerating (48-h, open bars) livers were harvested and
homogenized and lipids extracted from homogenates. The composition of the major phospholipid classes phosphatidylcholine (PC),
phosphatidylethanolamine (PE), phosphatidylinositol (PI), phosphatidylserine (PS), sphingomyelin (SM), cardiolipin (diphosphatidylglycerol, DPG),
lysophosphatidylcholine (LPC) and phosphatidic acid (PA) were determined by phosphorous analysis after their separation by thin-layer-
chromatography. Results are shown as mol% of total phosphorous. Data and presented as means 6 SD and are representative of three independent
experiments using cohorts of 6 WT and 6 E2F2-/- mice each. Statistical differences between the regenerating and the quiescent liver of a genotype are
denoted by * P#0.05, ** P#0.01, and between the same tissue condition of different genotypes are denoted by # P#0.05 (unpaired, 2-tailed
Student’s t-test).
doi:10.1371/journal.pone.0112620.g002
Figure 3. E2F2 gene deletion modifies the acyl diversity of major phospholipid classes. Partial hepatectomy was performed on E2F2+/+
(wild-type, WT) and E2F2-/- (KO) mice, and were sacrificed 48 hours later. Quiescent (0-h) and regenerating (48-h) livers were harvested and
homogenized and lipids extracted from homogenates. The fatty acid composition of phosphatidylcholine (PC), phosphatidylethanolamine (PE),
phosphatidylserine (PS), phosphatidylinositol (PI) and sphingomyelin (SM) were determined by gas chromatography analysis after their separation by
thin-layer-chromatography. Only the data values for quiescent livers are shown as profiles in regenerating livers are highly similar. Results are
expressed as mol% of the total fatty acid in each phospholipid class and presented as means6 SD of two independent experiments using cohorts of
6 WT and 6 E2F2-/- mice each. Statistical differences between the same tissue condition of different genotypes are denoted by# P#0.05 (unpaired, 2-
tailed Student’s t-test).
doi:10.1371/journal.pone.0112620.g003
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[28], and different aliquots were taken for either the determination
of TAG, or total lipid phosphorus and FA composition or for the
separation of PL by thin-layer-chromatography. Aliquots were
stored at 280uC under N2 until analysis.
TAG was quantified by commercial kits used in clinical settings
(Boehringer Mannheim Gmbh, Mannheim, Germany), according
to the manufacturer’s instructions. Phosphorus content of PL
classes was determined after isolation by thin-layer-chromatogra-
phy using chloroform:methanol:acetic acid:water (50:37:3.5:2, v/
v) as the solvent system in saturated chambers [29]. Phospholipid
spots were visualized by iodine vapor staining and scraped for
phosphorus analysis [30]. Phospholipid classes for FA analysis
were isolated using a chloroform:methanol:amonium (65:25:5, v/
v) and chloroform:acetone:methanol:acetic acid:water
(30:40:10:10:3, v/v) two dimensional solvent system. Phospholipid
spots were located after spraying the plates with dichlorofluor-
escein in methanol, scraped and eluted with chloroform/metha-
nol/acetic acid/water (50:39:1:10, v/v) [31]. Eluted sphingomy-
elin (SM) was subjected to three successive steps for purification:
mild alkaline treatment (0.5 N NaOH in anhydrous methanol at
50uC for 10 min), re-extraction by addition of chloroform and
0.5 N HCl to the methanolic phase and thin-layer-chromatogra-
phy separation using chloroform:methanol:acetic acid:0.15 M
NaCl (50:25:8:2.5, v/v) [32].
FA composition of lipids was determined by gas-chromatogra-
phy of their FA methyl ester derivatives prepared by keeping the
lipid samples overnight at 45uC under N2 in the presence of
anhydrous methanol containing 0.5 N H2SO4 in Teflon lined,
screw capped tubes [33]. Before gas-chromatography FA methyl
esters were purified using pre-washed silica gel G thin-layer-
chromatography plates with methanol:ether (75:25, v/v) and
hexane:ether (95:5, v/v) as the solvent system. FA methyl esters
were visualized on the plates using dichlorofluorescein and
recovered from the silica after thorough mixing and partition
between water:methanol:hexane (1:1:1, v/v/v) in three successive
hexane extractions. A Varian 3700 gas chromatograph equipped
with two (2 m62 m) glass columns packed with 10% SP 2330 on
Chromosorb WAW 100/120 (Supelco, Inc.) was used. The
column oven temperature was programmed from 155uC to
230uC at a rate of 5uC/min, and then kept at the upper
temperature for about 10 min. Injector and detector temperatures
were set at 220 and 230uC, respectively, and N2 (30 ml/min) was
the carrier gas. The FA peaks were detected with flame ionization
detectors, operated in the dual-differential mode, and quantified
by electronic integration (Varian Workstation).
Figure 4. E2F2 gene deletion promotes changes in transcript expression of selected genes involved in phospholipid and fatty acid
metabolism. Partial hepatectomy was performed on E2F2+/+ (wild-type, WT) and E2F2-/- mice, and were sacrificed 48 hours later. Quiescent (0-h,
solid bars) and regenerating (48-h, open bars) livers were harvested and total RNA from each mouse was examined in triplicate by quantitative real-
time PCR for the following genes: Pemt, phosphatidylethanolamine N-methyltransferase; Chpt1, choline phosphotransferase 1; Cept1, choline/
ethanolamine phosphotransferase 1; Pebp1, phosphatidylethanolamine binding protein 1; Sptlc2, serine palmitoyltransferase, long chain base
subunit 2; Fads2, fatty acid desaturase 2; Scd1, stearoyl-CoA desaturase 1. Relative transcript abundance was calculated for each mouse using a
normalization factor computed by Genorm software for pyruvate carboxylase, transferrin receptor and vascular endothelial zinc finger containing
factor 1 mRNAs. Values are referred to 0-h WT mice samples (100%). Results are presented as means 6 SD (n = 8 mice per group), except for Scd1
transcript levels, which were estimated in 3 pools of eight mice each from each genotype (n = 3). Statistical differences between regenerating and
quiescent liver of a genotype are denoted by ** P#0.01, *** P#0.001, and between the same tissue condition of different genotypes are denoted by
# P#0.05, ## P#0.01, ### P#0.001 (unpaired, 2-tailed Student’s t-test).
doi:10.1371/journal.pone.0112620.g004
E2F2 Deletion Disrupts Liver Lipid Homeostasis
PLOS ONE | www.plosone.org 4 November 2014 | Volume 9 | Issue 11 | e112620
T
a
b
le
1
.
Fa
tt
y
ac
id
co
m
p
o
si
ti
o
n
o
f
to
ta
l
lip
id
s
in
w
ild
-t
yp
e
(W
T
)
an
d
E2
F2
-/
-
m
ic
e
liv
e
r
b
e
fo
re
(0
-h
)
an
d
4
8
h
o
u
rs
(4
8
-h
)
p
o
st
-p
ar
ti
al
h
e
p
at
e
ct
o
m
y.
F
a
tt
y
a
ci
d
W
T
m
ic
e
li
v
e
r
E
2
F
2
-/
-
m
ic
e
li
v
e
r
0
-h
4
8
-h
0
-h
4
8
-h
%
%
%
%
1
4
:0
0
.3
6
0
.1
0
.8
6
0
.1
0
.2
6
0
.0
4
0
.7
6
0
.1
1
4
:1
n
-9
0
.0
4
6
0
.0
2
0
.1
6
0
.0
4
*
0
.0
4
6
0
.0
1
0
.1
6
0
.0
3
1
5
:0
0
.1
6
0
.0
1
0
.1
6
0
.0
2
0
.1
6
0
.0
1
0
.1
6
0
.0
2
1
5
:1
n
-9
0
.0
1
6
0
.0
1
1
0
.1
6
0
.0
1
*
0
.0
3
6
0
.0
0
5
0
.1
6
0
.0
1
1
6
:0
2
0
.9
6
0
.8
1
9
.7
6
0
.5
*
2
0
.8
6
1
.3
1
7
.9
6
0
.6
1
6
:1
n
-9
2
.1
6
0
.4
5
.2
6
1
.5
*
2
.2
6
0
.3
4
.5
6
0
.6
1
7
:0
0
.3
6
0
.0
5
0
.2
6
0
.0
2
*
0
.3
6
0
.0
2
0
.1
6
0
.0
1
1
7
:1
n
-9
0
.2
6
0
.0
1
0
.3
6
0
.0
3
0
.2
6
0
.0
1
0
.2
6
0
.1
1
8
:0
1
0
.9
6
1
.3
3
.6
6
1
.0
*
1
0
.6
6
1
.4
3
.8
6
0
.6
1
8
:1
n
-9
1
6
.7
6
1
.2
2
7
.3
6
0
.8
*
1
9
.5
6
0
.5
2
6
.5
6
0
.7
1
8
:2
n
-6
2
3
.8
6
1
.9
3
0
.8
6
0
.5
*
2
3
.0
6
2
.2
3
3
.5
6
0
.2
#
1
8
:3
n
-6
0
.4
6
0
.1
0
.7
6
0
.2
0
.4
6
0
.1
0
.6
6
0
.2
1
8
:3
n
-3
0
.8
6
0
.2
1
.4
6
0
.3
0
.8
6
0
.2
1
.7
6
0
.2
2
0
:2
n
-6
0
.3
6
0
.0
3
0
.6
6
0
.1
0
.4
6
0
.1
0
.5
6
0
.1
2
0
:3
n
-9
0
.5
6
0
.0
5
0
.7
6
0
.0
2
0
.5
6
0
.1
0
.7
6
0
.1
2
0
:3
n
-6
1
.0
6
0
.1
0
.9
6
0
.2
1
.0
6
0
.2
0
.8
6
0
.1
2
0
:4
n
-6
1
1
.8
6
1
.1
3
.4
6
0
.7
*
1
1
.1
6
1
.3
3
.9
6
0
.7
2
0
:5
n
-3
0
.6
6
0
.2
0
.3
6
0
.0
2
0
.8
6
0
.1
0
.4
6
0
.1
2
2
:4
n
-6
0
.2
6
0
.1
0
.0
3
6
0
.0
1
0
.2
6
0
.1
0
.0
3
6
0
.0
2
2
2
:5
n
-6
0
.9
6
0
.1
0
.5
6
0
.1
0
.8
6
0
.1
0
.5
6
0
.1
2
2
:5
n
-3
0
.9
6
0
.2
0
.5
6
0
.1
0
.8
6
0
.1
0
.3
6
0
.1
2
2
:6
n
-3
7
.2
6
0
.8
3
.0
6
0
.8
*
6
.3
6
0
.4
3
.0
6
0
.6
SF
A
3
2
.5
6
2
.7
2
4
.4
6
1
.3
*
3
2
.0
6
2
.2
2
2
.6
6
1
.6
M
U
FA
1
9
.1
6
0
.7
3
2
.9
6
1
.4
*
2
1
.9
6
1
.7
3
1
.4
6
2
.4
P
U
FA
n
-6
3
8
.1
6
4
.0
3
6
.4
6
1
.3
3
6
.5
6
3
.4
3
9
.3
6
1
.8
P
U
FA
n
-3
9
.5
6
0
.7
5
.1
6
0
.4
*
8
.7
6
1
.3
5
.5
6
0
.4
n
-6
/n
-3
4
.0
6
0
.2
7
.1
6
0
.9
4
.2
6
0
.4
7
.1
6
0
.7
U
n
sa
t.
In
d
e
x
1
8
1
.6
1
4
5
.0
1
7
1
.8
1
6
6
.7
C
1
6
2
3
.0
2
4
.9
2
3
.0
2
2
.4
C
1
8
5
2
.6
6
3
.8
5
4
.3
6
6
.1
C
2
0
1
4
.2
5
.9
1
3
.8
6
.3
C
2
2
9
.2
4
.0
8
.1
3
.8
T
h
e
re
su
lt
s
ar
e
e
xp
re
ss
e
d
as
a
p
e
rc
e
n
ta
g
e
o
f
th
e
fa
tt
y
ac
id
s
m
e
as
u
re
d
in
th
e
co
rr
e
sp
o
n
d
in
g
to
ta
ll
ip
id
sa
m
p
le
an
d
ar
e
th
e
av
e
ra
g
e
6
SD
o
f
tw
o
in
d
e
p
e
n
d
e
n
t
e
xp
e
ri
m
e
n
ts
u
si
n
g
co
h
o
rt
s
o
f
6
E2
F2
+/
+
(w
ild
-t
yp
e
,W
T
)
an
d
6
E2
F2
-/
-
m
ic
e
e
ac
h
.S
FA
,s
at
u
ra
te
d
fa
tt
y
ac
id
s;
M
U
FA
,m
o
n
o
u
n
sa
tu
ra
te
d
fa
tt
y
ac
id
s;
P
U
FA
,p
o
ly
u
n
sa
tu
ra
te
d
fa
tt
y
ac
id
s.
St
u
d
e
n
t’
s
t-
te
st
fo
r
p
ai
re
d
d
at
a:
*
P
#
0
.0
5
fo
r
co
m
p
ar
is
o
n
s
o
f
4
8
-h
vs
0
-h
w
it
h
in
th
e
sa
m
e
g
e
n
o
ty
p
e
;#
P
#
.0
5
fo
r
co
m
p
ar
is
o
n
s
o
f
th
e
sa
m
e
co
n
d
it
io
n
b
e
tw
e
e
n
E2
F2
-/
-
an
d
W
T
g
ro
u
p
s.
d
o
i:1
0
.1
3
7
1
/j
o
u
rn
al
.p
o
n
e
.0
1
1
2
6
2
0
.t
0
0
1
E2F2 Deletion Disrupts Liver Lipid Homeostasis
PLOS ONE | www.plosone.org 5 November 2014 | Volume 9 | Issue 11 | e112620
T
a
b
le
2
.
Fa
tt
y
ac
id
co
m
p
o
si
ti
o
n
o
f
tr
ia
cy
lg
ly
ce
ro
ls
in
w
ild
-t
yp
e
(W
T
)
an
d
E2
F2
-/
-
m
ic
e
liv
e
r
b
e
fo
re
(0
-h
)
an
d
4
8
h
o
u
rs
(4
8
-h
)
p
o
st
-p
ar
ti
al
h
e
p
at
e
ct
o
m
y.
F
a
tt
y
a
ci
d
W
T
m
ic
e
li
v
e
r
E
2
F
2
-/
-
m
ic
e
li
v
e
r
0
-h
4
8
-h
0
-h
4
8
-h
%
%
%
%
1
4
:0
0
.6
5
6
0
.1
8
0
.6
2
6
0
.1
0
0
.5
0
6
0
.0
4
0
.8
2
6
0
.1
7
1
4
:1
n
-9
0
.0
7
6
0
.0
4
0
.0
7
6
0
.0
4
0
.0
5
6
0
.0
2
0
.1
2
6
0
.0
3
1
5
:0
0
.1
3
6
0
.0
1
0
.1
6
0
.0
2
0
.1
2
6
0
.0
3
0
.1
3
6
0
.0
2
1
5
:1
n
-9
0
.0
4
6
0
.0
1
1
0
.0
6
6
0
.0
2
0
.0
4
6
0
.0
2
0
.0
8
6
0
.0
3
1
6
:0
2
1
.5
6
0
.8
5
1
6
.2
6
0
.5
9
*
2
1
.1
6
0
.9
5
1
7
.9
6
0
.4
5
1
6
:1
n
-9
3
.9
8
6
0
.3
6
3
.1
0
6
0
.8
2
3
.6
8
6
0
.3
3
5
.2
0
6
0
.3
9
1
7
:0
0
.1
7
6
0
.0
7
0
.1
5
6
0
.0
6
0
.1
9
6
0
.0
2
0
.1
2
6
0
.0
4
1
7
:1
n
-9
0
.2
5
6
0
.0
1
0
.2
3
6
0
.0
3
0
.2
6
6
0
.0
1
0
.3
1
6
0
.1
0
1
8
:0
2
.1
4
6
0
.4
3
2
.9
2
6
0
.7
5
2
.0
6
6
0
.3
5
1
.8
7
6
0
.6
0
1
8
:1
n
-9
2
6
.5
6
1
.1
2
9
.0
6
0
.7
3
1
.1
6
0
.5
#
2
8
.1
6
0
.8
1
8
:2
n
-6
3
3
.5
6
1
.3
3
4
.5
6
0
.6
*
3
1
.3
6
1
.4
3
5
.1
6
0
.6
1
8
:3
n
-6
0
.8
1
6
0
.1
0
0
.7
5
6
0
.2
5
0
.5
7
6
0
.1
6
0
.6
1
6
0
.1
2
1
8
:3
n
-3
1
.8
7
6
0
.2
1
1
.2
0
6
0
.2
9
1
.6
6
6
0
.2
4
2
.0
3
6
0
.1
7
2
0
:2
n
-6
0
.4
7
6
0
.0
8
1
.0
5
6
0
.1
0
0
.6
7
6
0
.0
9
0
.5
6
6
0
.1
1
2
0
:3
n
-9
0
.6
0
6
0
.0
9
1
.2
0
6
0
.1
3
0
.7
4
6
0
.1
0
0
.7
3
6
0
.1
5
2
0
:3
n
-6
0
.7
8
6
0
.1
4
1
.5
9
6
0
.2
9
0
.8
4
6
0
.1
6
0
.8
6
6
0
.1
3
2
0
:4
n
-6
2
.6
7
6
0
.7
2
2
.4
2
6
0
.5
5
2
.1
2
6
0
.5
8
2
.2
0
6
0
.4
7
2
0
:5
n
-3
0
.4
0
6
0
.2
2
0
.2
6
6
0
.0
5
0
.3
4
6
0
.0
6
0
.3
0
6
0
.1
0
2
2
:4
n
-6
0
.6
4
6
0
.0
9
0
.8
7
6
0
.0
4
0
.5
0
6
0
.0
7
0
.4
3
6
0
.0
2
#
#
#
#
2
2
:5
n
-6
0
.3
4
6
0
.0
5
0
.4
9
6
0
.0
2
0
.2
9
6
0
.0
6
0
.2
4
6
0
.0
4
#
2
2
:5
n
-3
0
.5
3
6
0
.2
0
0
.6
2
6
0
.0
3
0
.3
7
6
0
.0
8
0
.3
3
6
0
.0
5
#
2
2
:6
n
-3
2
.0
1
6
0
.0
9
2
.4
8
6
0
.2
0
1
.6
3
6
0
.1
3
1
.9
4
6
0
.4
6
SF
A
2
4
.6
6
1
.7
2
0
.0
6
1
.3
2
3
.9
6
1
.2
2
0
.9
6
1
.4
M
U
FA
3
0
.7
6
0
.5
3
2
.4
6
1
.2
3
5
.0
6
1
.3
#
3
3
.7
6
2
.0
P
U
FA
n
-6
3
9
.2
6
4
.0
4
1
.7
6
1
.1
3
6
.3
6
2
.6
4
0
.1
6
1
.3
P
U
FA
n
-3
4
.8
6
0
.6
4
.6
6
0
.5
4
.0
6
1
.0
4
.6
6
0
.6
n
-6
/n
-3
8
.2
6
1
.3
9
.1
6
0
.9
9
.1
6
0
.4
8
.7
6
0
.7
U
n
sa
t.
In
d
e
x
1
4
1
1
5
0
1
3
4
1
4
2
C
1
6
2
5
.4
1
9
.3
2
4
.7
2
3
.1
C
1
8
6
4
.8
6
8
.4
6
6
.6
6
7
.7
C
2
0
4
.9
6
.5
4
.7
4
.6
C
2
2
3
.5
4
.5
2
.8
2
.9
T
h
e
re
su
lt
s
ar
e
e
xp
re
ss
e
d
as
a
p
e
rc
e
n
ta
g
e
o
f
th
e
fa
tt
y
ac
id
s
m
e
as
u
re
d
in
th
e
co
rr
e
sp
o
n
d
in
g
tr
ia
cy
lg
ly
ce
ro
ls
am
p
le
an
d
ar
e
th
e
av
e
ra
g
e
6
SD
o
f
tw
o
in
d
e
p
e
n
d
e
n
t
e
xp
e
ri
m
e
n
ts
u
si
n
g
co
h
o
rt
s
o
f
6
E2
F2
+/
+
(w
ild
-t
yp
e
,W
T
)
an
d
6
E2
F2
-/
-
m
ic
e
e
ac
h
.S
FA
,s
at
u
ra
te
d
fa
tt
y
ac
id
s;
M
U
FA
,m
o
n
o
u
n
sa
tu
ra
te
d
fa
tt
y
ac
id
s;
P
U
FA
,p
o
ly
u
n
sa
tu
ra
te
d
fa
tt
y
ac
id
s.
St
u
d
e
n
t’
s
t-
te
st
fo
r
p
ai
re
d
d
at
a:
*P
#
0
.0
5
fo
r
co
m
p
ar
is
o
n
s
o
f
4
8
-h
vs
0
-h
w
it
h
in
th
e
sa
m
e
g
e
n
o
ty
p
e
;#
P
#
0
.0
5
an
d
#
#
P
#
0
.0
1
fo
r
co
m
p
ar
is
o
n
s
o
f
th
e
sa
m
e
co
n
d
it
io
n
b
e
tw
e
e
n
E2
F2
-/
-
an
d
W
T
g
ro
u
p
s.
d
o
i:1
0
.1
3
7
1
/j
o
u
rn
al
.p
o
n
e
.0
1
1
2
6
2
0
.t
0
0
2
E2F2 Deletion Disrupts Liver Lipid Homeostasis
PLOS ONE | www.plosone.org 6 November 2014 | Volume 9 | Issue 11 | e112620
RNA preparation and gene expression analysis by
quantitative real-time PCR
Total RNA was extracted from liver tissue (100 mg) using
TRIzol reagent (Invitrogen), purified (RNeasy Mini kit, Qiagen),
DNase I-treated (Invitrogen) and re-purified according to the
manufacturers’ instructions. The purity and concentration of RNA
was determined with a NanoDrop ND-1000 UV-Vis spectropho-
tometer (NanoDrop Technologies). The 260/280 nm absorbance
ratio of samples was in the 1.8–2.1 range. RNA integrity was
further assessed by running samples in 1% agarose gel electro-
phoresis. cDNA was synthesized from 3.6 mg total RNA using the
SuperScript III First-Strand Synthesis System for reverse tran-
scription PCR kit (Invitrogen) according to the manufacturer’s
recommendations. For quantitative real-time PCR analyses of
target mRNA levels TaqMan Gene Expression Assays (Applied
Biosystems) were used. References of TaqMan assays were the
following: Mm00839436_m1 for phosphatidylethanolamine N-
methyltransferase (Pemt, GI:33667035); Mm00772290_m1 for
stearoyl-CoA desaturase 1 (Scd1, GI:118130513);
Mm01208299_g1 for fatty acid desaturase 2 (Fads2,
GI:9790070); Mm00522694_m1 for choline phosphotransferase
1 (Chpt1, GI:38604066); Mm01200029_g1 for choline/ethanol-
amine phosphotransferase 1 (Cept1, GI:142365741);
Mm02601848_g1 for phosphatidylethanolamine binding protein
1 (Pebp1, GI:84794551); and Mm00448878_m1 for serine
palmitoyltransferase, long chain base subunit 2 (Sptlc2,
GI:142366849). The relative quantities of each gene were
determined by the DDCt method. Normalization was performed
using normalization factors computed by GeNorm for pyruvate
carboxylase (Pcx, Mm00500992_m1), transferrin receptor (Tfrc,
Mm00441941_m1) and vascular endotelial zinc finger containing
factor 1 (Vezf1, Mm00497288_m1) mRNAs, as detailed previ-
ously [5].
Statistical analysis
Lipid composition results are presented as means 6 SD.
Statistical analyses were performed using GraphPad Prism v5.02
for Windows (GraphPad Software, San Diego, CA). Significance
was determined by the Student’s t-test for unpaired data for
comparisons between two individual data groups or for paired
data for comparisons of FA composition values. A P#0.05 value
was considered statistically significant unless otherwise stated.
Results
Deregulated expression of lipid metabolism genes in
E2F2-deficient liver
To better understand the connection between E2F2 activity and
lipid metabolism, we re-evaluated microarray raw data of
quiescent E2F2+/+ and E2F2-/- mice liver transcriptomes that we
had gathered in a previous study [5]. These data have been
deposited in the ArrayExpress repository (www.ebi.ac.uk/
arrayexpress) under accession number E-MEXP-1413. The
microarray analysis produced an unexpectedly large number of
deregulated codes (2915), 59.5% of which were upregulated and
40.5% of which were downregulated in the liver of E2F2-/-
compared with WT mice (P#0.01) (Table S1). Gene Ontology
(GO) analysis of the deregulated genes identified eleven GO terms
with a significant enrichment according to Bonferroni (P#0.05)
and Benjamini-Hochberg (P#0.01) multiple testing corrections
(Table S2). Remarkably, nine GO Biological Processes were linked
to core metabolic pathways in which ‘‘lipid metabolic process’’ was
the second most enriched GO term after ‘‘transport’’, showing a
false discovery rate close to zero. A set of sequences encoding 208
lipid metabolism-associated proteins (73.1% upregulated and
26.9% downregulated) was identified as E2F2-dependent (Table
S3). We found alterations in mutant mice compared to control in
the expression of essential genes involved in the following
processes: mitochondrial (i.e. Acad10, Acsl1, Atp5g3, Abcd2,
Cpt2, Slc25a24, Ucp2) and peroxisomal (i.e. Pecr, Slc27a5) FA
oxidation; FA synthesis (i.e. Acot11, Faah, Fads1, Fads2, Ffar2,
Scd1) and precursor use of FA (i.e. Cyp2c37, Ptgs2); glycerolipid
metabolism (i.e. Abhd4, Acaa1b, Atp8a1, Cav1, Cds2, Chka,
Chpt1, Etnk2, Far1, GK2, Lpcat3, Lpin3, Ocrl, Pcyt2, Ptdss1,
Ptdss2, phospholipases as Ddhd2, Enpp2, Ppap2a, Ppap2b and
Pnpla6, and phosphoinositides signaling related genes); sphingo-
lipid metabolism (i.e. Naaa, Sptlc3, Smpd3, Sgms1, St3gal6,
St6galnac6, Sult1e1, B3galt5, Ugcg), as well as genes involved in
steroid metabolism and bile secretion (i.e. Abcb4, Slc10a7, Soat1,
Srebf2) and plasma lipid transport and metabolism (i.e. Afp, Apob,
Apobec2, Abca2, Lrp1, Lrp3, Sulf2). These genetic alterations
argue that mice lacking E2F2 could display abnormalities in
hepatic lipid balance. These findings prompted us to further
investigate the role of E2F2 in liver lipid homeostasis in vivo, and
to examine if the PL and FA composition of quiescent and
regenerating (48-h) liver tissue was dependent on E2F2 gene
activity.
Hepatic phospholipid composition is altered in E2F2-
deficient mice
Mouse liver total TAG, PL and protein content (mg per g of
liver) were assessed in quiescent state and after PH (Figure 1).
Regenerating WT liver tissue was richer in TAG (6-fold increase)
and protein (0.2-fold increase) than quiescent WT liver, whereas
the concentration of PL per gram of liver remained constant.
Similar results were obtained in E2F2-/- mice, suggesting that the
shift from PL to TAG as the dominant lipid component in the
tissue ongoing regeneration is E2F2-independent.
To evaluate whether E2F2 activity has an effect on PL
distribution we determined the relative proportion of each PL
class by measuring the phosphorous content of the major PL
classes after thin-layer-chromatography separation, both in
quiescent and regenerating livers (Figure 2). Liver PL distribution
in quiescent liver was markedly different between WT and E2F2-/-
mice. PC and PE were the major PL classes in quiescent WT liver,
and accounted for ,52% and ,22% of PL content, respectively.
Remarkably, we found that PC levels were lower (30%) and that
PE levels were significantly higher (69%) in quiescent E2F2-/- liver
tissue relative to WT counterparts. Consequently, the hepatic PC/
PE ratio in quiescent tissue was much lower in E2F2-/- mice
(0.987) compared to E2F2+/+ mice (2.375), indicating that E2F2
gene activity contributes to sustain the homeostasis of the two
major membrane phospholipid classes when cells do not
proliferate. Likewise, the ratio of choline-containing PL (PC+
LPC+SM) versus amino-containing PL (PE+PS) was lower in
E2F2-/- mice liver (2.138) compared to WT (1.002). 48 hours after
partial hepatectomy, PC and PE percentages (Figure 2) as well as
the PC:PE ratio in WT livers changed significantly relative to
quiescence resembling percentages found in quiescent E2F2-/-
liver samples. These parameters remained unchanged in regen-
erating E2F2-/- tissue, indicating that no further proliferation-
driven quantitative adjustments were required in the absence of
E2F2. Altogether our results indicate that E2F2 gene deletion not
only alters the PL homeostasis in Q0/Q1 (resembling the PC:PE
ratio of proliferating WT tissue) but also constrains the normal
response of the liver to regeneration-associated signals that control
PC and PE homeostasis. By contrast to major PL classes, neither
E2F2 deficiency nor regeneration signals affected significantly the
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relative abundance of the minor amino-phospholipid phosphati-
dylserine (PS), the choline-phospholipids lysophosphatidylcholine
(LPC) and sphingomyelin (SM), phosphatidylinositol (PI), cardio-
lipin (diphosphatidylglycerol, DPG) or the intermediate phospha-
tidic acid (PA).
Fatty acid profiling of WT and E2F2-deficient mouse livers
To test whether E2F2 gene is required for normal esterification
of FA into lipids, and to maintain homeostasis of liver lipids, we
determined the FA composition of total lipids 48 hours after PH
and compared to the pre-PH composition in WT and E2F2-/-
mouse liver samples (Table 1). The global hepatic FA composition
was consistently similar in quiescent WT and E2F2-/- mice and the
regeneration induced changes were E2F2-independent. The most
abundant FA in the liver of the mouse strains used here were 18:1
(oleic acid) of the n-9 family, 18:2 (linoleic acid) and 20:4
(arachidonic acid, AA) of the n-6 family, 22:6 (docosahexaenoic
acid, DHA) of the n-3 family, and the saturated fatty acids (SFA)
16:0 (palmitic acid) and 18:0 (stearic acid). At 48-h post-PH, SFA,
mostly 18:0, decreased (WT, 25%; E2F2-/-, 29%) and the
monounsaturated fatty acids (MUFA, 18:1n-9 and 16:1n-9)
increased (WT, 72%; E2F2-/-, 43%), whereas total n-6 polyun-
saturated fatty acids (PUFA) did not change. Interestingly, the
marked decrease in the pro-inflammatory AA (WT, 72%; E2F2-/-,
65%) was compensated by the increase in its precursor linoleic
acid (WT, 30%; E2F2-/-, 45%). Anti-inflammatory n-3 PUFA
decreased (WT, 47%; E2F2-/-, 37%) due to DHA reduction.
Remarkably, in regenerating liver, C18 fatty acids represented
nearly 65% of the fatty acids, and the proportion of products to
precursor 20:5+22:6/18:3n-3 and 20:4/18:2n-6 dropped to one
fourth. Since the overall changes were similar in the two
genotypes, it is possible that repression of elongase activity and
activation of D9 desaturase activity during regeneration be
independent of E2F2 activity. Only two of the parameters
measured at 48-h post-PH were indeed sensitive to E2F2 loss:
the rise in 18:2n-6, which was 50% higher in the absence of E2F2,
and the 20% decrease in unsaturation index, which was not
apparent in E2F2-/- mice.
The differences in the FA composition of total lipid in liver
regeneration described above were consistent with previous
reports on proliferating cells [34]. To determine if the changes
observed in the total lipid FA composition reflected specific
modifications in the FA species of one or more lipids, or if they
were the consequence of the relative contribution of different
amount of lipids to the total pool, we performed a comprehensive
FA composition analysis of major liver lipids, namely TAG
(Table 2) and the phospholipids PC, PE, PS, PI, and SM
(Figure 3). Major fatty acids in TAG were 16:0, 18:1n-9 and
18:2n-6. Interestingly, the only changes induced by PH were
modest decreases in the percentage of 16:0 and increases in 18:2n-
6, indicating that the FA composition of newly synthesized TAG
that accumulate massively in lipid droplets was almost identical to
that of pre-existing TAG. Since 18:1n-9 and 18:2n-6 are major
TAG-FA, the six-fold increase in the content of TAG at 48-h
following PH was likely accounting for the increase observed in
these two FA in total lipids. Data indicate that E2F2 has a minor
influence on the hepatic TAG-FA composition, either in
quiescence, where it affects the 18:1 contribution (,25% higher
in mice that lack E2F2) and the MUFA proportion, or in
regeneration, where it affects the low abundant 22C fatty acids.
The FA composition of PL classes was remarkably similar
before and 48 hours after PH, and E2F2 deletion caused similar
changes in quiescent and regenerating tissue (Figure 3 and data
not shown). Six fatty acids (16:0, 18:0, 18:1n-9, 18:2n-6, 20:4n-6
and 22:6n-3) accounted for ,95% of total FA chains in liver
glycerophospholipids. Analysis of the phospholipid classes revealed
a significant reduction in PC and PS 20:4n-6 and in PE 18:1n-9
and a significant increase in PE and PS 18:2n-6, and PS 22:6n-3 in
E2F2-/- compared to WT. The singular FA composition of hepatic
SM was slightly different in mutant mice, with exchange of very-
long-chain saturated 24:0 and 23:0 for 18:0 and 18:1n-9. Our
results indicate that, besides the abnormal low proportion of PC to
PE in quiescence, constitutive E2F2 deletion in mice leads to
reorganization of the molecular species of hepatic PC, PE, PS and
SM. Since these changes are sustained during normal proliferation
of liver cells, loss of E2F2 could have a potential impact on
multiple membrane-dependent cell processes.
E2F2 gene deletion deregulates the expression of genes
involved in phospholipid synthesis
To further investigate the role of E2F2 on the relative
proportion of PC and PE levels and on elongase/desaturase
activity, we determined by quantitative real-time PCR the
transcript expression levels of several genes involved in lipid
metabolism that appeared deregulated in our initial microarray
analysis [5]. The selected genes were Pemt, Chpt1, Cept1, Pebp1,
Sptlc1, Fads2 and Scd1 (Figure 4). Our findings indicate that
Chpt1, the gene encoding the enzyme that synthesizes PC through
the CDP-choline pathway, is markedly down-regulated in
quiescent E2F2-/- mice liver compared with WT mice, and
additionally repressed in regenerating liver (see Figure 5 for a
schematic representation of the major metabolic pathways that
generate PC and PE in the liver). No differences were observed for
any experimental condition and genotype in Pemt expression,
responsible for the liver-exclusive methylation of PE to form PC.
However, the Cept1 gene, which is involved in the biosynthetic
pathway leading to PE was upregulated in mutant mice and
unaffected by regeneration. Notably, Sptlc2, responsible for
sphingosine synthesis was downregulated by E2F2 loss and
upregulated in regenerating tissue in the two strains. Conversely,
Scd1 was dramatically downregulated in regenerating tissue in the
two strains. Downregulation of Pebp1 and Fads2 is associated with
proliferation only in the absence of E2F2, and the hepatectomy-
promoted decrease in Chpt1 and Scd1 expression is more marked
in E2F2 deficient as compared with WT liver, suggesting that
E2F2 may modulate the transcriptional repression induced by
regenerative signals on certain genes.
Discussion
The studies reported here were designed to characterize the in
vivo role of E2F2 transcription factor in liver lipid homeostasis.
This question was raised by our own previous data that implicated
E2F2 in the timely mobilization of the LDs accumulated during
the post-PH regenerative process [5]. A subsequent finding from
our group also showed that the expression of numerous genes
involved in the hepatic ‘‘lipid metabolism process’’ was deregu-
lated in the liver of E2F2 nullizygous mice in quiescence (Tables
S2 and S3). Here we have shown that E2F2 sustains normal
hepatic PC to PE ratios and appears to function as a
transcriptional regulator of genes required for the synthesis of
these two major phospholipids, contributing also to the acylic
diversity of membrane glycerolipids and sphingomyelins in
proliferating and non-proliferating liver tissue.
A PC to PE ratio close to 2.5 is crucial for normal membrane
function, and variations of this proportion are commonly
associated with cell proliferation [35], but also with disease [36].
Lipids in biological membranes are asymmetrically distributed
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across the bilayer with most of the amine-containing PE (and PS)
localized in the inner leaflet and the choline-containing PC (and
LPC and SM) in the outer leaflet [37]. But lipid asymmetry cannot
be maintained when PC is insufficient, which may trigger
apoptosis in cells [38,39], or if the PC/PE ratio decreases, as is
commonly found in patients clinically diagnosed with non-
alcoholic steatohepatitis (1.2 versus 2.5 in normal controls) or in
animal models of choline deficient diet-induced steatohepatitis
[36]. Contrary to the changes observed in livers from these
animals (decreased content of PC levels and no change or a minor
increase of PE) [36,38], quiescent E2F2-/- livers contained
increased abundance of PE and no change or a tendency to
decrease of PC (Figure 2). Accordingly, the hepatic PC to PE ratio
(PC+LPC+SM to PE+PS ratio) drops markedly (0.987 (1.002)
versus 2.375 (2.138) in WT controls) in response to the loss of
E2F2. Following a canonical way of thinking, this suggests that
some surface PC (a cylindrical, bilayer molecule) might be
replaced by the inverted cone-shaped PE in the liver membranes
of E2F2-/- mice, potentially leading to defective curvature and
packing of cell membranes as well as defective activity of integral
proteins [37]. As part of the physiological events culminating in
cell division [40], cell membranes of proliferating cells have a
PC:PE ratio around 1 [35], which returns to quiescent levels after
cytokinesis [40]. However, this phenotype is chronically displayed
by liver membranes in cells that are in G0 in E2F2
-/- mice,
suggesting that the loss of functional E2F2 could potentially affect
multiple yet undetermined membrane-dependent cell processes.
Notably, GO analysis of deregulated hepatic genes in E2F2-/- mice
revealed that the biological process most robustly affected by the
loss of E2F2 is ‘‘transport’’, having a false discovery rate and
Benjamini and Bonferroni P values equal to 0 (Table S2).
Phospholipid metabolism and its regulation are remarkably
complex. In mammalian liver, PC is made from choline via the
CDP-choline (Kennedy) pathway for de novo synthesis, the Lands
cycle for remodeling of the FA composition of PC species [41,42]
and the liver-exclusive PE N-methyltransferase (PEMT)-driven
methylation of PE [43–45]. In the Kennedy pathway, choline is
activated sequentially with ATP and CTP and transferred to
diacylglycerol to form PC mainly by the enzymes encoded by
Chka, Pcyt1a and Chpt1. The Kennedy pathway and the Lands
cycle operate in PE synthesis using analogous reactions to PC
synthesis. A third PE source is mitochondrial PS decarboxylation,
while subsequent base-exchange reactions catalyzed by PS
synthase between PC (Ptdss1) or PE (Ptdss2) and serine generate
PS. PS synthase 2 can also work in reverse producing PE from PS
[45] (Figure 5). In line with the increased levels of PE in E2F2-/-
(Figure 2), we found upregulated expression of metabolic tran-
scripts governing the de novo synthesis of PE (Cept1 in Figure 4
and Etnk2 in Table S3) in mice lacking E2F2, suggesting that their
transcription is repressed by E2F2 in normal liver. Also loss of
E2F2 alters choline metabolism genes and E2F2 seems to regulate
the expression of enzymes involved in the initial and final steps of
Figure 5. Scheme representing E2F2 as a regulator of the major metabolic pathways that generate phosphatidylcholine and
phosphatidylethanolamine in the mammalian liver. The name in bold between parentheses corresponds to the gene coding for the dominant
isoform in adult liver. Constitutive deletion of E2F2 gene promotes increased phosphatidylethanolamine (PE) relative content, a low
phosphatidylcholine (PC):PE ratio, increased expression of genes required for PE formation and deregulated expression of some genes involved
both in the Kennedy pathway for PC synthesis and the deacylation:reacylation arm of PC turnover. Such permanent decrease in the PC:PE ratio may
impact phospholipid-related biological responses. CTP, cytidinetriphosphate; CDP, cytidinediphosphate; LPC, lysophosphatidylcholine, PA,
phosphatidic acid; TAG, triacylglycerol. The Lands (deacylation-reacylation) cycle consists of phospholipases A2 (or A1) and acyl:CoA lysophospholipid
acyltransferases. We only show here the deacylation/reacylation of phosphatidylcholine. Transcript upregulations are shown in red and
downregulations in green.
doi:10.1371/journal.pone.0112620.g005
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the CDP-choline pathway in opposing ways. PC synthesis is
primarily controlled by CTP: phosphocholine cytidyltransferase a
(CTa) translocation to membranes [43–45] and secondarily by
transcriptional regulation of involved genes [41]. Work on
transcriptional regulation of the CTa-encoding gene Pcyt1a
revealed that it is repressed by the complex Sp1/E2F-retinoblas-
toma-histone deacetylase in quiescent mouse embryonic fibro-
blasts [46]. We found similar levels of Pcyt1 expression in
quiescent WT and mutant mice liver (Table S3), suggesting that
E2F2 is unlikely to be the E2F family member contributing to
transcriptional repression of the rate limiting enzyme of PC
synthesis. Comparing with wild type mice, PC levels were
unaffected or tended to decrease (Figure 2) whereas the transcript
levels of the gene controlling choline kinase, Chka, increased four-
fold in quiescent E2F2-/- liver (Table S3). It is possible that
phosphocholine is formed in excess but cannot be effectively
transformed to PC when E2F2 is disrupted. The opposite trends
of changes in PC and PE levels during quiescence and the
concerted downregulation of choline phosphotransferase and
upregulation of ethanolamine phosphotransferase found in mice
lacking E2F2 in quiescent and proliferating liver (Figure 4) support
the concept that E2F2 transcription factor may affect the
partitioning of common intermediates ATP, CTP and DAG
towards de novo PE and PC synthesis, controlling cellular PE and
PC provision.
A characteristic feature of liver regeneration is the accumulation
of LDs in the tissue [1,4]. We have shown that hepatic TAG levels
are similar in WT and mutant mice either in quiescence or at 48h-
post PH (Figure 1), suggesting that TAG synthesis is not under
E2F2 control. Previous work has shown that the massive hepatic
steatosis occurring during the first 3–4 days of regeneration in WT
mice persisted over 7 days in E2F2 knockout mice [5], suggesting a
defective mobilization of stored TAG in this condition. Hepatic
LDs are metabolically active organelles [47,48] composed of a
core of neutral lipids, mainly TAG and cholesteryl esters,
surrounded by a monolayer of PL in which LD-associated proteins
are embedded. The biological properties and functions of these
proteins is matter of intense study. PC has been identified as an
essential molecule for LDs turnover, acting as a surfactant to
prevent LDs coalescence and formation of large, lipase-resistant
droplets [49]. While LDs are able to synthesize PC locally by the
Lands cycle [50], during LDs expansion, the additional PC
required to coat the enlarging surface is mostly provided by the
Kennedy pathway [49]. Hence, the activity of the CDP-choline
pathway dictates the rate at which the stored TAG may be
accessible to intracellular lipases. Further studies will be required
to quantify the LD-associated metabolites and enzymatic activities
involved in TAG turnover during the regeneration period. We
propose that the chronically limited PC supply in E2F2-deficent
liver cells might contribute to the late mobilization of TAG during
liver regeneration in E2F2-/- mice.
Diversity of acyl moieties in cellular glycerophospholipids
depends on the specificity of acyltransferases involved in de novo
pathways [51] but mostly on the remodeling catalyzed by
phospholipases A2, transacylases and lysophospholipid acyltrans-
ferases (for recent reviews see [42,52]). E2F2 activity affects the
acyl diversity of hepatic PC, PE, PS and SM (Figure 3) but not of
PI, DPG (Figure 3), total lipids (Table 1) and TAG (Table 2). The
major desaturases (Scd1, Fads2) and elongases (Elovl6/Fasn) are
essential in supporting life-sustaining cellular processes. The global
changes during regeneration are similar in the two strains
(Figure 4 and [5]). It is intriguing why the proliferative liver
maintains basically the same TAG fatty acid composition
(Table 2) after a drastic increase in the amount of TAG being
synthesized (Figure 1). A possibility is that TAG may serve as
donors of DAG and/or fatty acyl chains for further incorporation
into other lipids. Thus, the increased synthesis of different
molecular species of TAG may be part of a metabolic adjustment
to provide different FA for esterification into complex lipids. TAG
might be then a metabolic transient store of glycerol and FA for de
novo synthesis of PL. However, this may not be the case for FA
with regulatory or precursor functions, whose changes in
regeneration are associated with PL, as they are mostly
incorporated in the remodeling cycle [42,52]. Desaturases and
elongases in mammalian cells transform the essential fatty acid
18:3n-3 (linolenic acid) into the long-chain n-3 anti-inflammatory
EPA and DHA and 18:2n-6 (linoleic acid) into the pro-
inflammatory AA, which are incorporated into lysophospholipids
[42] prior to act as substrates for several oxygenase enzymes.
PUFAs are thus major sources of fatty acid-derived lipid mediators
[53,54]. The balance between n-6 and n-3 PUFA families is
particularly important during recovery from PH, as this is a pro-
inflammatory situation. Indeed, the regenerative pressure led to
similar global increases in the n-6/n-3 ratio and to the
maintenance of constant proportions of essential fatty acids
(Table 1). However, there were specific increases in PE and PS
18:2n-6, decreases in PC and PS 20:4n-6 and increases in PS
22:6n-3 (Figure 4) in response to E2F2 loss in quiescence that were
sustained during normal proliferation of liver cells, indicating that
E2F2 is necessary for regulation of these fatty acids that play a
significant role in physiopathological responses. Notably, the
changes in FA composition of PS matched the acyl diversity of the
PC and PE pools illustrating the complete reliance on their PC
and PE substrates (Figure 5). The expression of numerous genes
encoding proteins with phospholipase A2 activity sensitive to
E2F2, such as Lpcat3, the main acyltransferase acting on lyso-PC,
-PS and -PE acceptors in the liver [42], and Plaa (Table S3), also
supports the role of E2F2 as modulator of PC, PE and PS
reacylation.
Considering that steady-state levels of E2F2 increased after PH
[27], that E2F2 activates the expression of the target genes
required for S-phase entry [55–57] and that PC synthesis is active
in the G1/S transition [58] it might be expected that E2F2 targets
the genes involved in PC and PE metabolism in proliferating cells.
However, findings in this and previous work [5], where a mouse
strain carrying a loss-of-function mutation in E2F2 has been
studied in quiescent and PH-associated liver regeneration,
demonstrate that the in vivo effects of E2F2 deficiency, either in
the PC:PE ratio or in the expression levels of lipid genes, are more
relevant in quiescent tissue. Paradoxically, the liver of E2F2-/-
mice harbors cells reluctant to enter S-phase after hepatectomy [5]
but displays a membrane phenotype resembling an exit from G0/
G1, regarding the low PC:PE ratio and Chka upregulation, both
markers for membrane proliferation [35,59]. Overexpression of
choline kinase and high levels of phosphocholine have been
detected, in fact, in several tumors compared to surrounding non-
cancerous tissue [60,61]. It is worthwhile to note that examination
of non-proliferating livers by microarray analysis has led to the
identification of an unexpectedly elevated number of genes whose
expression is deregulated (59.5% upregulated and 40.5% down-
regulated) in response to E2F2 deletion (Table S1). This supports
dual functions for E2F2 in the liver, acting both as transcriptional
repressor and activator, as was also found in other cell types
[21,23,62]. E2F2 deletion resulted in a broad impact on core
metabolic processes in normal liver (Table S2). Although,
obviously, many of these effects may be indirect or due to
compensation by members of the E2F family [63], our findings
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support the concept that E2F2 may have a role in metabolic
homeostasis.
In conclusion, our data clearly demonstrate that the phenotype
of adult liver carrying a constitutive E2F2 deletion includes
deregulated expression of a set of 208 genes linked to lipid
metabolism, leading to an aberrantly low proportion of PC to PE
and abnormal acyl diversity in defined phospholipids that is
maintained during regeneration. Further functional research is
needed to determine the direct role of E2F2 on phospholipid
metabolism in hepatocytes, the main functional cells of the organ,
which will also provide additional insight into the complex
relationship between membrane lipids and transcription factors
mastering cell-cycle control.
Supporting Information
Table S1. E2F2 deletion deregulates the expression of a
large number of sequences in quiescent liver. Original
data were extracted from the Affymetrix microarray data
deposited in MIAME ArrayExpress database (www.ebi.ac.uk/
arrayexpress) under accession code E-MEXP-1413. We used six
RNA pools, three pools of E2F2+/+ (wild-type, WT) (n = 24) and
three pools of E2F2-/- (n = 24) mice genotypes. Each pool
contained quiescent liver samples from 8 animals. Affymetrix
chips and microarray data analysis were performed exactly as
described in Ref. 5. TIGR MultiExperiment Viewer Mev version
4.1 (Institute of Genomic Research, Rockville, MD) was used for
the statistical analysis of the microarray data. To identify the genes
whose expression levels changed significantly in E2F2-/- compared
with WT mice we used Welch’s t-test with a P#0.01 significance
level cut-off. After curation, 2915 sequences were found to elicit
significant expression change in quiescent liver upon E2F2 loss; of
them 1735 (59.5%) were upregulated and 1180 (40.5%) were
downregulated.
(XLSX)
Table S2 Overrepresented Gene Ontology functional
categories in quiescent E2F2-/- liver relative to wild-type
controls. aRefers to the number of genes included in each
overrepresented functional category. bRefers to the percentage of
genes detected in each functional category relative to the total
number of genes included in that particular category. Functional
classification of deregulated genes was made using FatiGO+, a
public domain web tool for finding significant associations of Gene
Ontology (GO) terms within groups of genes. Statistical signifi-
cance was determined by Fischer’s exact test and P-values were
adjusted applying Benjamini-Hochberg (P#0.01) and Bonferroni
(P#0.05) multiple testing correction.
(DOCX)
Table S3 E2F2 deletion deregulates the expression of a
set of genes involved in lipid metabolism in quiescent
liver. Genes (208) were extracted from the identified sequences
listed in Table S1, categorized by our own criterion and shown in
alphabetic order. Of them, 152 (73.1%) were up-regulated and 56
(26.9%) were down-regulated in the liver of E2F2 nullizygous mice
in quiescence.
(DOCX)
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